Roivant Sciences Ltd. ( ROIV) - Key Metrics
ROIV Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $0 | -$0.26 | -$0.37 | -$0.37 |
| 2025Q4 | $0 | $0.43 | -$0.23 | -$0.24 |
| 2025Q3 | $0 | -$0.38 | -$0.28 | -$0.27 |
| 2025Q2 | $0 | -$0.17 | -$0.27 | -$0.28 |
| 2025Q1 | $0 | -$0.33 | -$0.30 | -$0.31 |
ROIV Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | -34.03 |
| 2025Q4 | 0% | 16.10 |
| 2025Q3 | 0% | -14.28 |
| 2025Q2 | 0% | -22.25 |
| 2025Q1 | 0% | -8.54 |
ROIV
Price: $35.72
52 week price:
Earnings Per Share: -0.47 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United Kingdom
Volume: 1.4 million
Market Capitalization: 25.0 billion